ALYSSA NISHIHIRA: Open Payments
NPI 1265880637 · RENO, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$400 in 15 payments from 11 companies in 2025. Trend: 2023 $2,200 · 2024 $565 · 2025 $400
Food & beverage: $400
| Company | Payments | Amount |
|---|---|---|
| MAYNE PHARMA COMMERCIAL LLC | 4 | $143 |
| Otsuka America Pharmaceutical, Inc. | 2 | $41 |
| Inspire Medical Systems, Inc. | 1 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| Sage Therapeutics, LLC | 1 | $24 |
| Sumitomo Pharma America, Inc. | 1 | $23 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $23 |
| Tris Pharma Inc | 1 | $21 |
| ABBVIE INC. | 1 | $20 |
| Lilly USA, LLC | 1 | $19 |
Products named: BIJUVA, REXULTI, INSPIRE, OFEV, ZURZUVAE, MYFEMBREE, LUMRYZ, Dyanavel XR.
Industry payments across NV — which companies pay providers there.
